Biorex Diagnostics has announced plans to expand with an investment of £2 million in a new custom build manufacturing facility in Antrim. Biorex Diagnostics, which develops, manufactures and distributes a range of medical diagnostic and point of care tests, is aiming to substantially increase its export sales, improve production processes and create an additional 30 jobs. The company currently employs
Press Release Partnership with ESfEQA, the European Society for External Quality Assessment Biorex Diagnostics are pleased to announce that we have formed a new partnership with ESfEQA, the European Society for External Quality Assessment.
Biorex Diagnostics has been at the forefront of laboratory diagnostic research, developing and manufacturing a comprehensive range of medical diagnostic products over the past decade. Our range encompasses -: Clinical Chemistry, Immunoassay, Quality Controls, Haemostasis, Serology and Haematology products. Biorex Diagnostics products are marketed in over 100 international markets and are renowned for their high quality & cost-effectiveness. More than
Biorex Diagnostics now manufactures a wide range of CLIA including Thyroid, Fertility, Tumour Markers. CHEMILUMINESCENCE ADVANTAGES • Most sensitive method over all other immunoassay technologies. • At least 10 times greater detection system. • Low background (High signal to noise ratio). • Higher Linearity. • Faster Incubation hence reduced assay time. • No protein quenching problem as in fluorescence.
Biorex Food Diagnostics launched in October 2014 and have been rapidly growing and expanding their food safety test product list. The newly released Streptomycin ELISA kit will increase their honey testing portfolio to 8 ELISA kits, taking into consideration the use of excellent generic antibodies this allows for the detection of 25 compounds in honey samples. Managing Director Dr Morteza
Biorex Diagnostics are please to announce the launch of our newly improved HbA1c Micro-column kit. HAEMOGLOBIN A1c MICRO COLUMN Intended Use: In vitro test for the determination of haemoglobin A1C concentration in blood. Test Principle: After preparing the haemolysate, where the labile fraction is eliminated, haemoglobins are retained by a cationic exchange resin, Haemoglobin A1c is specifically eluted after washing